Guidelines for the Production Linked Incentive (PLI) Scheme

Date: 18th August, 2022

File No. 31026/19/2020-MD
Government of India
Ministry of Chemicals and Fertilizers
Department of Pharmaceuticals
Dated: 18th August, 2022

Guidelines for the Production Linked Incentive (PLI) Scheme for Promoting: Domestic Manufacturing of Medical Devices
1. Background
1.1. The Medical Device sector in India suffers from a considerable cost of manufacturing disability vis-a-vis competing economies, inter alia, on account of lack of adequate infrastructure, domestic supply chain and logistics, high cost of finance, inadequate availability of power, limited design capabilities and low focus on research and development (R&D) and skill development etc. Thus, a need was felt for a mechanism to compensate for this manufacturing disability in order to ensure a level playing field for the domestic manufacturers of medical devices. To compensate for the manufacturing disability in selected segments of medical devices, the Government of India has come out with a scheme called ‘Production Linked Incentive Scheme (PLI) for promoting domestic manufacturing of Medical Devices’ (hereinafter referred to as ‘Scheme’) which has been notified vide Gazette Notification no. 31026/08/2020-MD, dated -21/07/2020.